Cargando…
Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants
Induced pluripotent stem cell (iPSC)-derived cell products hold great promise as a potential cell source in personalized medicine. As concerns about the potential risk of graft-related severe adverse events, such as tumor formation from residual pluripotent cells, currently restrict their applicabil...
Autores principales: | Dahlke, Julia, Schott, Juliane W., Vollmer Barbosa, Philippe, Klatt, Denise, Selich, Anton, Lachmann, Nico, Morgan, Michael, Moritz, Thomas, Schambach, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234706/ https://www.ncbi.nlm.nih.gov/pubmed/34204193 http://dx.doi.org/10.3390/jpm11060565 |
Ejemplares similares
-
Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020) -
Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes
por: Klatt, Denise, et al.
Publicado: (2019) -
Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages
por: Hoffmann, Dirk, et al.
Publicado: (2021) -
Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment
por: Klatt, Denise, et al.
Publicado: (2020) -
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections
por: Ackermann, Mania, et al.
Publicado: (2018)